文献速递银屑病与炎症性皮肤病

内皮Skp2/PTEN轴在血管生成与银屑病中的关键作用

A critical role of the endothelial S-phase kinase-associated protein 2/phosphatase and tensin homologue axis in angiogenesis and psoriasis.
PubMed 文献 · Br J Dermatol · 2024-01-01

该研究探讨E3连接酶Skp2在银屑病中的作用。在患者皮肤和IMQ小鼠模型中Skp2升高,且与真皮乳头血管增多相关;Skp2通过泛素化PTEN降解促血管生成,内皮特异性敲除Skp2或局部使用Skp2抑制剂C1可改善小鼠银屑病。提示靶向Skp2驱动的血管生成可能是银屑病治疗方向。

要点

  • Skp2在银屑病皮损和IMQ小鼠模型中表达升高,且与真皮乳头血管增多相关。
  • Skp2通过泛素化PTEN并促其降解来促进内皮细胞增殖、迁移和成管。
  • 内皮特异性Skp2敲除或局部Skp2抑制剂C1可减轻小鼠银屑病及乳头血管生成。

核心结论

  • Skp2/PTEN轴可能在银屑病相关血管生成中起重要作用。
  • 靶向Skp2驱动的血管生成可能是治疗银屑病的潜在途径。

研究设计与样本

  • 研究检测银屑病 vulgaris 患者皮肤样本和IMQ诱导小鼠模型及培养内皮细胞中的基因表达与蛋白水平。
  • 使用人脐静脉内皮细胞、人真皮微血管内皮细胞及多种体内外血管生成实验。
  • 使用Skp2全身敲除小鼠和内皮特异性条件敲除小鼠,以及Skp2选择性抑制剂C1。

主要发现

  • Skp2在银屑病患者皮肤和IMQ诱导小鼠皮损中升高。
  • 免疫荧光双染显示Skp2表达与皮损真皮乳头过度血管分布密切关联。
  • 在HDMECs中,Skp2过表达增强而敲低抑制内皮细胞增殖、迁移和管样结构形成。
  • PTEN被鉴定为Skp2介导泛素化的新底物;Skp2抑制剂C1或Skp2 siRNA显著减少VEGF触发的PTEN泛素化与降解。
  • Skp2基因缺陷减轻IMQ诱导的银屑病;他莫昔芬诱导的内皮特异性Skp2敲除小鼠银屑病显著改善且乳头血管生成减少;局部使用C1有效预防实验性银屑病。

关键数值与推荐

  • Skp2抑制剂C1或Skp2小干扰RNA显著降低VEGF触发的PTEN泛素化和降解。
  • Skp2介导的泛素化依赖于糖原合成酶激酶3β对PTEN的磷酸化。

临床怎么用

  • 局部使用Skp2抑制剂C1在IMQ小鼠模型中有效预防实验性银屑病。
  • 内皮特异性Skp2敲除显著改善小鼠银屑病并减少乳头血管生成。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psoriasis is a common chronic skin disorder. Pathologically, it features abnormal epidermal proliferation, infiltrating inflammatory cells and increased angiogenesis in the dermis. Aberrant expression of E3 ubiquitin ligase and a dysregulated protein ubiquitination system are implicated in the pathogenesis of psoriasis. OBJECTIVES: To examine the potential role of S-phase kinase-associated protein 2 (Skp2), an E3 ligase and oncogene, in psoriasis. METHODS: Gene expression and protein levels were evaluated with quantitative reverse transcriptase polymerase chain reaction, Western blotting, immunohistochemistry and immunofluorescence staining of skin samples from patients with psoriasis vulgaris and an imiquimod (IMQ)-induced mouse model, as well as from cultured endothelial cells (ECs). Protein interaction, substrate ubiquitination and degradation were examined using co-immunoprecipitation, Western blotting and a cycloheximide chase assay in human umbilical vein ECs. Angiogenesis was measured in vitro using human dermal microvascular ECs (HDMECs) for BrdU incorporation, migration and tube formation. In vivo angiogenesis assays included chick embryonic chorioallantoic membrane, the Matrigel plug assay and quantification of vasculature in the mouse lesions. Skp2 gene global knockout (KO) mice and endothelial-specific conditional KO mice were used. RESULTS: Skp2 was increased in skin samples from patients with psoriasis and IMQ-induced mouse lesions. Immunofluorescent double staining indicated a close association of Skp2 expression with excessive vascularity in the lesional dermal papillae. In HDMECs, Skp2 overexpression was enhanced, whereas Skp2 knockdown inhibited EC proliferation, migration and tube-like structure formation. Mechanistically, phosphatase and tensin homologue (PTEN), which suppresses the phosphoinositide 3-kinase/Akt pathway, was identified to be a novel substrate for Skp2-mediated ubiquitination. A selective inhibitor of Skp2 (C1) or Skp2 small interfering RNA significantly reduced vascular endothelial growth factor-triggered PTEN ubiquitination and degradation. In addition, Skp2-mediated ubiquitination depended on the phosphorylation of PTEN by glycogen synthase kinase 3β. In the mouse model, Skp2 gene deficiency alleviated IMQ-induced psoriasis. Importantly, tamoxifen-induced endothelial-specific Skp2 KO mice developed significantly ameliorated psoriasis with diminished angiogenesis of papillae. Furthermore, topical use of the Skp2 inhibitor C1 effectively prevented the experimental psoriasis. CONCLUSIONS: The Skp2/PTEN axis may play an important role in psoriasis-associated angiogenesis. Thus, targeting Skp2-driven angiogenesis may be a potential approach to treating psoriasis.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Xie X, Cui Q, Jiang T, et al. A critical role of the endothelial S-phase kinase-associated protein 2/phosphatase and tensin homologue axis in angiogenesis and psoriasis. Br J Dermatol. 2024. PMID: 37850885. doi:10.1093/bjd/ljad399

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。